Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 6.25
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 0
  • Market Cap: £157.29m
  • RiskGrade: 268

Regulatory News

Further detail from G306 Phase III field trial 07-May-2024 07:00 RNS
Director Resignation 03-Apr-2024 07:00 RNS
Interim Results for six months ended 31 Dec 2023 27-Mar-2024 07:00 RNS
Update on funding 27-Mar-2024 07:00 RNS
VLP Peanut PROTECT Trial Update 12-Mar-2024 08:59 RNS
Appointment of Shaun Furlong to Board of Directors 11-Mar-2024 07:00 RNS
Result of AGM 08-Mar-2024 13:49 RNS
Half-Year Trading Update 2024 14-Feb-2024 07:00 RNS
Notice of 2023 Annual General Meeting 09-Feb-2024 15:07 RNS
Restoration - Allergy Therapeutics plc 30-Jan-2024 07:30 RNS
Publication of Annual Report and Accounts 2023 30-Jan-2024 07:00 RNS
Total Voting Rights 04-Jan-2024 12:29 RNS
Suspension - Allergy Therapeutics plc 02-Jan-2024 07:30 RNS
Amendment to existing Facility Agreement 27-Dec-2023 12:01 RNS
Annual Report and Accounts Delayed 15-Dec-2023 12:48 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 3.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 6.25
52 Week Low 0.88
Volume 0
Shares Issued 4,766.44m
Market Cap £157.29m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.26% below the market average19.26% below the market average19.26% below the market average19.26% below the market average19.26% below the market average
9.80% above the sector average9.80% above the sector average9.80% above the sector average9.80% above the sector average9.80% above the sector average
Price Trend
29.83% below the market average29.83% below the market average29.83% below the market average29.83% below the market average29.83% below the market average
1.82% above the sector average1.82% above the sector average1.82% above the sector average1.82% above the sector average1.82% above the sector average
Income Not Available
Growth
84.18% below the market average84.18% below the market average84.18% below the market average84.18% below the market average84.18% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average

AGY Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

AGY Key Personnel

CEO Manuel Llobet

Top of Page